InsidersTradesSigma
Track the 浩欧博 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 浩欧博 has recorded 3 public disclosures. Market capitalisation: €5.7bn. The latest transaction was filed on 6 July 2026 (Sale). Among the most active insiders: 陈小三. The full history is accessible without an account.
3
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€181,250
3 ops.
Sell Volume
4Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,018 of 29,063 companies
49.2
score / 100
Value37
Quality62
FCF yld-0.0%
Earn yld0.4%
EV/EBITDA·
ROE3.4%
Gross mgn58%
Net mgn5.8%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 July 2026
Acerca de 浩欧博
浩欧博 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en la Bolsa de Shanghái. Se enfoca en el desarrollo y distribución de productos farmacéuticos.